Evidence map›Paper›PMID 35167715›Full record

ArticleClinical endocrinology2022

Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling.

Marianna Viukari, Eeva Kokko, Ilkka Pörsti, Helena Leijon, Tiina Vesterinen, Tero Hinkka, Minna Soinio, Camilla Schalin-Jäntti, Niina Matikainen, Pasi I Nevalainen

Open access · greenAbstract read
In one paragraph

Article in Clinical endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Marianna ViukariEndocrinology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0001-9720-5026
Eeva KokkoFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Ilkka PörstiFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Helena LeijonDepartment of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Tiina VesterinenDepartment of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Tero HinkkaDepartment of Radiology, Centre for Vascular Surgery and Interventional Radiology, Tampere University Hospital, Tampere, Finland.
Minna SoinioDepartment of Endocrinology, Turku University Hospital, Turku, Finland.
Camilla Schalin-JänttiEndocrinology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Niina MatikainenEndocrinology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Pasi I NevalainenDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland.
University of Helsinki · FITampere University · FITampere University Hospital · FITurku University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe examined if measurement of adrenal androgens adds to subtype diagnostics of primary aldosteronism (PA) under cosyntropin-stimulated adrenal venous sampling (AVS).

designA prospective pre-specified secondary endpoint analysis of 49 patients with confirmed PA, of whom 29 underwent unilateral adrenalectomy with long-term follow-up.

methodsConcentrations of androstenedione, dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulphate (DHEAS) were measured during AVS in addition to aldosterone and cortisol. Subjects with lateralisation index (LI) of ≥4 were treated with unilateral adrenalectomy, and the immunohistochemical subtype was determined with CYP11B2 and CYP11B1 stains. The performance of adrenal androgens was evaluated by receiver operating characteristics (ROC) curve analyses in adrenalectomy and medical therapy groups.

resultsDuring AVS, the correlations between cortisol and androstenedione, DHEA and DHEAS for LI and selectivity index (SI) were highly significant. The right and left side SIs for androstenedione and DHEA were higher (p < .001) than for cortisol. In ROC analysis, the optimal LI cut-off values for androstenedione, DHEA and DHEAS were 4.2, 4.5 and 4.6, respectively. The performance of these LIs for adrenal androgens did not differ from that of cortisol.

conclusionsUnder cosyntropin-stimulated AVS, the measurement of androstenedione and DHEA did not improve the cannulation selectivity. The performance of cortisol and adrenal androgens are confirmatory but not superior to cortisol-based results in lateralisation diagnostics of PA.

Indexed as

HyperaldosteronismAdrenal GlandsAldosteroneAndrogensAndrostenedioneCosyntropinDehydroepiandrosteroneHumansHydrocortisoneProspective StudiesRetrospective StudiesAldosteroneAndrogensAndrostenedioneCosyntropinDehydroepiandrosteroneHydrocortisoneadrenal androgensadrenal venous samplingaldosterone producing adenomabilateral adrenal hyperplasiaCYP11B2primary aldosteronismsubtype classification of primary aldosteronism

Identifiers

PMID35167715
PMCPMC9544970
OpenAlexW4213353122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.